SCHEMBL4355830

SCHEMBL4355830

CS(c1ccccc1)(c1ccccc1)c1ccccc1.O=C(OCC(F)(F)S(=O)(=O)O)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
GAA P10253 2/20 0.47
RECQL P46063 1/20 0.42
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CYP17A1 P05093 2/20 0.39
CYP19A1 P11511 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ENPP3 O14638 1/20 0.39
CA2 P00918 1/20 0.39
ENPP1 P22413 1/20 0.39
ENPP2 Q13822 1/20 0.39
CA9 Q16790 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358883 0.90 ALDH1A1 (0.48) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL2610451 0.84 ALDH1A1 (0.44) ALDH1A1GAARECQLKMT2ACYP17A1
SCHEMBL1398391 0.83 ALDH1A1 (0.43) ALDH1A1GAARECQLKMT2ACYP17A1
SCHEMBL4358021 0.82 ALDH1A1 (0.43) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL4358881 0.81 ALDH1A1 (0.44) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL3454419 0.81 GAA (0.43) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL1398383 0.81 ALDH1A1 (0.48) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL2422774 0.81 ALDH1A1 (0.39) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL2422772 0.80 RECQL (0.41) ALDH1A1GAARECQLKMT2ASMN1; SMN2
SCHEMBL1262662 0.79 ALDH1A1 (0.38) ALDH1A1GAAKMT2ACYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8779183-B2 Acid generating agent for chemically amplified resist compositions KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2014-07-15 US disclosed
US-20090234155-A1 Acid generating agent for chemically amplified resist compositions KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090234155-A1 Acid generating agent for chemically amplified resist compositions POLM, CBR1, PFAS ALDH1A1 346/4885GAA 3920/4885RECQL 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.